Conventional Imaging in Adrenocortical Carcinoma: Update and Perspectives

Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204

Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV et al (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238(2):578–585

Sangwaiya MJ, Boland GW, Cronin CG, Blake MA, Halpern EF, Hahn PF (2010) Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT–10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 256(2):504–510

Brenner DJ, Hall EJ (2007) Computed tomography–an increasing source of radiation exposure. N Engl J Med 357(22):2277–2284

Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 165(3):579–583

Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA (2004) Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 183(1):215–219

Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231(3):711–716

Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171(3):675–680

Yip L, Tublin ME, Falcone JA, Nordman CR, Stang MT, Ogilvie JB et al (2010) The adrenal mass: correlation of histopathology with imaging. Ann Surg Oncol 17(3):846–852

Dunnick NR, Heaston D, Halvorsen R, Moore AV, Korobkin M (1982) CT appearance of adrenal cortical carcinoma. J Comput Assist Tomogr 6(5):978–982

Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS (1987) Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 148(3):531–535

Hedican SP, Marshall FF (1997) Adrenocortical carcinoma with intracaval extension. J Urol 158(6):2056–2061

Copeland PM (1983) The incidentally discovered adrenal mass. Ann Intern Med 98(6):940–945

Chiche L, Dousset B, Kieffer E, Chapuis Y (2006) Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 139(1):15–27

Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H et al (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2):479–485

Slattery JM, Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM et al (2006) Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol 187(1):W21–W24

Tucci S Jr, Martins AC, Suaid HJ, Cologna AJ, Reis RB (2005) The impact of tumor stage on prognosis in children with adrenocortical carcinoma. J Urol 174(6):2338–2342, discussion 42